INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 457m ago
HOUSE PTR57m ago
SEC 13F57m ago
ROBINHOOD CHAIN57m ago
DC
Corporate insider

Davis Todd C

Director, Chief Executive OfficerCIK 0001392029

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells2 / 0
Max Insider Score47
Connections with evidence2

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
18
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Other acquisition or disposition
J$21K
132 sh
Jun 30, 2026Jul 6, 2026
traded Jun 30, 2026
+6dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Pelthos Therapeutics Inc.Director · Jun 15, 2026
  • Insider ofevidence
    LIGAND PHARMACEUTICALS INCDirector, Chief Executive Officer · Dec 8, 2025
47
DC
Davis Todd CDirector
PTHSPelthos Therapeutics Inc.
Open-market purchase
BUY
$986K
35.4K sh
Jun 11, 2026
Jun 15, 2026
traded Jun 11, 2026
+4d
SEC FORM 4

Evidence

29
DC
Davis Todd CDirector
PTHSPelthos Therapeutics Inc.
Open-market purchase
BUY$14K
503 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

23
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
10.5K sh
Mar 2, 2026Mar 27, 2026
traded Mar 2, 2026
+25dSEC FORM 4

Evidence

19
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
50.1K sh
Mar 2, 2026Mar 27, 2026
traded Mar 2, 2026
+25dSEC FORM 4

Evidence

12
DC
Davis Todd CDirector, Chief Executive Officer
LGNDLIGAND PHARMACEUTICALS INC
Gift
G—
130 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence